JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144498

DL-AP5 sodium salt (mM/ml), NMDA glutamate site antagonist

Be the first to review this product! Submit a review

|

(3 Publications)

MW 219.11 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. Achieve your results faster with highly validated, pure and trusted compounds.

View Alternative Names

AMPA 1, AMPA-selective glutamate receptor 1, GLUH1, GRIA1_HUMAN, GluA1, GluR-1, GluR-A, GluR-K1, Glutamate receptor 1, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, HBGR1, MGC133252, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243

1 Images
Chemical Structure - DL-AP5 sodium salt (mM/ml), NMDA glutamate site antagonist (AB144498)
  • Chemical Structure

Lab

Chemical Structure - DL-AP5 sodium salt (mM/ml), NMDA glutamate site antagonist (AB144498)

2D chemical structure image of ab144498, DL-AP5 sodium salt (mM/ml), NMDA glutamate site antagonist

Key facts

CAS number

1303993-72-7

Purity

>99%

Form

Solid

form

Molecular weight

219.11 Da

Molecular formula

C<sub>5</sub>H<sub>1</sub><sub>1</sub>NNaO<sub>5</sub>P

PubChem

52974251

Nature

Synthetic

Biochemical name

DL-AP5 Sodium salt

Biological description

Competitive NMDA receptor glutamate site antagonist.

Canonical smiles

C(CC(C(=O)O)N)CP(=O)(O)[O-].[Na+]

InChi

InChI=1S/C5H12NO5P.Na/c6-4(5(7)8)2-1-3-12(9,10)11;/h4H,1-3,6H2,(H,7,8)(H2,9,10,11);/q;+1/p-1

InChiKey

KWRCYAPNGUCHOE-UHFFFAOYSA-M

IUPAC Name

sodium;(4-amino-4-carboxybutyl)-hydroxyphosphinate

style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
style
left-column
style
left-column
style
left-column

Product protocols

style
left-column

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

PloS one 15:e0226797 PubMed31940316

2020

Ultrastructure of light-activated axons following optogenetic stimulation to produce late-phase long-term potentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Masaaki Kuwajima,Olga I Ostrovskaya,Guan Cao,Seth A Weisberg,Kristen M Harris,Boris V Zemelman

Hippocampus 22:516-33 PubMed21254303

2011

Adrenergic modulation of sharp wave-ripple activity in rat hippocampal slices.

Applications

Unspecified application

Species

Unspecified reactive species

R Ul Haq,A Liotta,R Kovacs,A Rösler,M J Jarosch,U Heinemann,C J Behrens

PloS one 5:e13964 PubMed21103043

2010

Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.

Applications

Unspecified application

Species

Unspecified reactive species

Bopanna I Kalappa,Alexander G Gusev,Victor V Uteshev
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Biochemicals

AB120003

D-AP5, NMDA glutamate site antagonist

Chemical Structure - D-AP5, NMDA glutamate site antagonist (AB120003)

  • 0
  • 0
Biochemicals

AB146698

NMDA (mM/ml), excitotoxic amino acid

  • 0
  • 0
Biochemicals

AB120042

SR95531 (Gabazine), GABAA antagonist

Chemical Structure - SR95531 (Gabazine), GABAA antagonist (AB120042)

  • 0
  • 0
Proteins & Peptides

AB259412

Recombinant human VEGF 165A protein (Active)

Premium Bioactive

Mass Spectrometry - Recombinant human VEGF 165A protein (Active) (AB259412)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com